Blog
RSS FeedPosted by Michael Wonder on 11 Mar 2018
Proposal to widen access and change the funded brand of tenofovir disoproxil and entecavir
9 March 2018 - PHARMAC is delighted to propose the widening of access to tenofovir disoproxil and entecavir, anti-viral medicines ...
Posted by Michael Wonder on 11 Mar 2018
The relative importance of clinical, economic, patient values and feasibility criteria in cancer drug reimbursement in Canada: a revealed preferences analysis of recommendations of the pan-Canadian Oncology Drug Review 2011–2017
20 January 2018 - Most Canadian provinces and territories rely on the pan-Canadian Oncology Drug Review to provide recommendations regarding public ...
Posted by Michael Wonder on 08 Mar 2018
CADTH Common Drug Review will accept submissions up to six months pre-Notice of Compliance
8 March 2018 - Operational change can help reduce the time between regulatory approval and reimbursement recommendations for prescription drugs ...
Posted by Michael Wonder on 08 Mar 2018
Patient and public involvement in early awareness and alert activities: an example from the United Kingdom
6 March 2018 - The aim of this study is to report on the experiences, benefits, and challenges of patient and ...
Posted by Michael Wonder on 08 Mar 2018
NICE u-turn on treatment for giant cell arteritis
8 March 2018 - Roche/Chugai’s RoActemra has now won the backing of NICE for the treatment of eligible patients with ...
Posted by Michael Wonder on 07 Mar 2018
Cancer sufferers want Oz treatments: 'I want to live'
7 March 2018 - A Tauranga woman with terminal breast cancer has had to fundraise over $100,000 to pay for a ...
Posted by Michael Wonder on 07 Mar 2018
Bupa tweaks controversial gap cover plan following public outcry
7 March 2018 - Health fund Bupa has admitted it went a step too far amid anger over changes to ...
Posted by Michael Wonder on 07 Mar 2018
PBS price disclosure – 42 month clock list (for a 30% unadjusted price reduction) for the 2018 April cycle
7 March 2018 - A list of drugs and manners of administration that meet the 42 month clock (for a 30% ...
Posted by Michael Wonder on 07 Mar 2018
Decision to change the funded brand of aripiprazole and remove listing restrictions
7 March 2018 - PHARMAC is pleased to announce the approval of an agreement with Novartis New Zealand Limited for ...
Posted by Michael Wonder on 06 Mar 2018
Access to new drugs for rare disorders in Canada
2 March 2018 - McMillan and Campbell believe that Canada needs a regulatory framework for the introduction of orphan drugs ...
Posted by Michael Wonder on 06 Mar 2018
Health Minister orders investigation into health insurer Bupa after alarming announcements
6 March 2018 - Federal Health Minister Greg Hunt has ordered the Private Health Insurance Ombudsman to investigate health fund ...
Posted by Michael Wonder on 06 Mar 2018
Agency for 7 March TC meeting
6 March 2018 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 05 Mar 2018
Record 30 per cent increase in complaints about health insurance
5 March 2018 - A startling 30% increase has seen the total number of complaints to the Private Health Insurance ...
Posted by Michael Wonder on 05 Mar 2018
NICE on the hunt for a director to lead the Centre for Health Technology Evaluation
5 March 2018 - The Director of the Centre for Health Technology Evaluation is responsible for delivering some of the most ...
Posted by Michael Wonder on 05 Mar 2018
NHS prescription charges are rising – here’s how to keep them down
3 March 2016 - Here’s what you need to know about the increase – and how to get cheaper everyday medicines. ...